BrianC.GadbawMD
Pediatric Hematology & Oncology • East Hanover, NJExecutive Medical Director - Pediatric Oncology Development
Dr. Gadbaw is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Novartis Pharmaceutical Corporation
1 Health Plaza
East Hanover, NJ 07936- Is this information wrong?
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Pediatric Hematology/Oncology, 2007 - 2010- University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 2004 - 2007
Michigan State University College of Human MedicineClass of 2004
Certifications & Licensure
WI State Medical License 2005 - 2011
Publications & Presentations
PubMed
- 16 citationsMultiple administrations of fluconazole increase plasma exposure to ruxolitinib in healthy adult subjectsVassilios Aslanis, Kenichi Umehara, Felix Huth, Taoufik Ouatas, Savita Bharathy, Andrew Avigdor Butler, Wen Zhou, Brian Gadbaw> ;Cancer Chemotherapy and Pharmacology. 2019 Jul 19
- 20 citationsEfficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies.Jean-Jacques Kiladjian, Paola Guglielmelli, Martin Griesshammer, Güray Saydam, Tamás Masszi, Simon Durrant, Francesco Passamonti, Mark M. Jones, Hui-Ling Zhen, Jingjin...> ;Annals of Hematology. 2018 Feb 2
- 56 citationsRuxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH trials.Madan Jagasia, Robert Zeiser, Michael C. Arbushites, Patricia Delaite, Brian Gadbaw, Nikolas von Bubnoff> ;Immunotherapy. 2018 Jan 10
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
